Goldman Sachs
LUMO

Goldman Sachs’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Goldman Sachs’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-362,198
Closed -$1.4M – 6342
2024
Q3 		$1.4M Sell
362,198
-44,413
-11% -$123K ﹤0.01% 4408
2024
Q2 		$943K Sell
406,611
-1
-0% -$3 ﹤0.01% 4448
2024
Q1 		$1.15M Buy
406,612
+1
+0% +$3 ﹤0.01% 4254
2023
Q4 		$1.29M Buy
406,611
+53
+0% +$181 ﹤0.01% 4234
2023
Q3 		$1.34M Sell
406,558
-386
-0.1% -$1.2K ﹤0.01% 4060
2023
Q2 		$1.34M Buy
406,944
+395
+0.1% +$1.39K ﹤0.01% 4146
2023
Q1 		$1.35M Sell
406,549
-62,818
-13% -$220K ﹤0.01% 4166
2022
Q4 		$1.69M Sell
469,367
-114,529
-20% -$749K ﹤0.01% 4064
2022
Q3 		$5.17M Buy
583,896
+227,909
+64% +$1.89M ﹤0.01% 3102
2022
Q2 		$2.74M Sell
355,987
-21
-0% -$168 ﹤0.01% 3761
2022
Q1 		$3.35M Buy
356,008
+18
+0% +$161 ﹤0.01% 3745
2021
Q4 		$2.47M Buy
+355,990
New +$2.99M ﹤0.01% 4074
2019
Q4 		– Sell
-2,268
Closed -$32K – 5449
2019
Q3 		$32K Sell
2,268
-20,936
-90% -$307K ﹤0.01% 5082
2019
Q2 		$309K Buy
+23,204
New +$350K ﹤0.01% 4608
2019
Q1 		– Sell
-2,681
Closed -$37K – 5513
2018
Q4 		$37K Sell
2,681
-6,209
-70% -$109K ﹤0.01% 5115
2018
Q3 		$191K Sell
8,890
-2,571
-22% -$78.2K ﹤0.01% 4937
2018
Q2 		$491K Buy
11,461
+1,690
+17% +$77.4K ﹤0.01% 4515
2018
Q1 		$638K Buy
9,771
+2,588
+36% +$183K ﹤0.01% 4334
2017
Q4 		$524K Buy
7,183
+1,748
+32% +$145K ﹤0.01% 4791
2017
Q3 		$498K Buy
5,435
+43
+0.8% +$3.3K ﹤0.01% 5088
2017
Q2 		$357K Sell
5,392
-19,704
-79% -$2.44M ﹤0.01% 5364
2017
Q1 		$5.44M Buy
25,096
+15,278
+156% +$2.18M ﹤0.01% 2863
2016
Q4 		$908K Buy
9,818
+8,392
+588% +$946K ﹤0.01% 4539
2016
Q3 		$193K Buy
1,426
+247
+21% +$24.5K ﹤0.01% 5854
2016
Q2 		$119K Sell
1,179
-10,750
-90% -$1.33M ﹤0.01% 6038
2016
Q1 		$1.95M Buy
11,929
+3,090
+35% +$626K ﹤0.01% 3493
2015
Q4 		$2.9M Buy
8,839
+7,547
+584% +$2.46M ﹤0.01% 3313
2015
Q3 		$416K Sell
1,292
-3,565
-73% -$1.57M ﹤0.01% 5325
2015
Q2 		$1.94M Sell
4,857
-3,283
-40% -$1.39M ﹤0.01% 3857
2015
Q1 		$4.01M Buy
8,140
+7,654
+1,575% +$2.97M ﹤0.01% 3107
2014
Q4 		$174K Sell
486
-1,091
-69% -$325K ﹤0.01% 6268
2014
Q3 		$304K Buy
1,577
+325
+26% +$71.5K ﹤0.01% 5744
2014
Q2 		$299K Sell
1,252
-160
-11% -$32.5K ﹤0.01% 5837
2014
Q1 		$361K Buy
1,412
+911
+182% +$278K ﹤0.01% 5581
2013
Q4 		$99K Sell
501
-19
-4% -$3.38K ﹤0.01% 6286
2013
Q3 		$88K Sell
520
-2,998
-85% -$483K ﹤0.01% 6189
2013
Q2 		$624K Buy
+3,518
New +$498K ﹤0.01% 4762

Goldman Sachs's LUMO Position: Q4 2024 in Review

Goldman Sachs sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 362,198 shares — an estimated $1.4M sold.

Goldman Sachs first reported a position in LUMO in Q2 2013 and held it in 37 quarters. The position peaked at $5.44M in Q1 2017. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Goldman Sachs reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Goldman Sachs sold 362,198 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $1.4M.
  • Goldman Sachs first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 37 quarters.
  • Goldman Sachs's Lumos Pharma, Inc. Common Stock position peaked at $5.44M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.